Top 10 Things to Consider When Designing Platform, Basket and Umbrella Clinical Trials
As clinical trials evolve, it is natural to feel overwhelmed with how to begin planning master protocols for new study designs – namely platform, basket and umbrella trials.
With the US Food and Drug Administration (FDA)’s draft guidance ‘Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics’ – it opens up a world of opportunities for sponsors and sites alike.
Through years of experience helping sponsors manage complex oncology trials, endpoint has established a deep understanding of the emphasis needed on continuously advancing eClinical technology to accommodate for the increasing complexities of trial management. In this webinar, learn how to efficiently and easily manage platform, basket and umbrella trials so sponsors and sites can focus on what matters most – the patient.
What You Will Learn
Participants will learn about:
- An understanding of the different types of master protocols (platform, basket and umbrella)
- Key considerations when planning these types of protocols and how to leverage advanced eClinical technology
- Benefits of running these types of trials for both sites and sponsors
- How these protocols result in more efficient time management and overall cost savings
Speaker: Cat Hall, VP Product Strategy, endpoint
Cat Hall started her career as an academic scientist in Molecular and Cellular before finishing her MBA and transitioning into Pharmaceutical Supply Chain Management. During her career, she developed notable expertise not only in clinical supplies but also in training development, process improvement, managing partnerships and the design and implementation of technologies such as Interactive Response Technology (IRT). She is well-known for focusing on bridging the GMP/GCP gap by bringing supply chain customer service through the last mile to patients. Cat joined endpoint in 2019 as VP of Product Strategy to help continue to bring the customer voice forward into shaping the future of IRT.